GlassScriptPhysician profile
Helen Lee
NPI 1023540796
$3,794.71
in general payments reported to CMS, 2019-2025
20 companies · $1,160 in 2025
The $1,160 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $457 · 2020: $210 · 2021: $272 · 2022: $403 · 2023: $371 · 2024: $922 · 2025: $1,160.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $646.47 | 2019-2025 | |
| Janssen Biotech, INC. | $480.41 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $297.90 | 2020-2025 | Dupixent, Libtayo |
| Incyte Corporation | $283.54 | 2022-2025 | Opzelura |
| Arcutis Biotherapeutics, INC. | $255.55 | 2023-2025 | Zoryve |
| Abbvie INC. | $253.70 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $232.41 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $190.21 | 2023-2025 | Sotyktu |
| Leo Pharma INC. | $183.49 | 2022-2024 | Adbry |
| Lilly USA, LLC | $160.76 | 2022-2025 | Ebglyss, Taltz |
| Sanofi-Aventis U.S. LLC | $136.95 | 2020-2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.34 | 2019 | |
| Ucb, INC. | $115.12 | 2024-2025 | Bimzelx |
| Pfizer INC. | $99.81 | 2023-2024 | |
| Galderma Laboratories, L.P. | $88.00 | 2024-2025 | Nemluvio |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $66.34 | 2022-2023 | Otezla |
| Organon LLC | $53.45 | 2025 | Vtama |
| Almirall LLC | $52.08 | 2024-2025 | Klisyri |
| Dermavant Sciences, INC. | $48.85 | 2024 | Vtama |
| Strata Skin Sciences, INC. | $30.33 | 2024 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.